Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

AIM To analyze the structure and expressions of the protein encoded by an HCC-associated novel gene, lysosome-associated protein transmembrane 4 beta (LAPTM4B). METHODS Primary structure and fundamental characteristics of LAPTM4B protein were analysed with bioinformatics. Expressions of LAPTM4B in HCC tissues and various cell lines were detected using polyclonal antibodies and Western blot. RESULTS LAPTM4B encoded two isoforms of proteins with molecular masses 35-ku and 24-ku, respectively. The expression level of LAPTM4B-35 protein in HCC tissues was dramatically upregulated and related to the differentiation status of HCC tissues, and it was also high in some cancer cell lines. Computer analysis showed LAPTM4B was an integral membrane protein with four transmembrane domains. LAPTM4B showed relatively high homology to LAPTM4A and LAPTM5 in various species. CONCLUSION LAPTM4B gene encoded two isoforms of tetratransmembrane proteins, LAPTM4B-35 and LAPTM4B-24. The expression of LAPTM4B-35 protein is upregulated and associated with poor differentiation in human HCC tissues, and also at high levels in some cancer cell lines. LAPTM4B is an original and conserved protein.

[1]  Jun Liu,et al.  Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma , 2003, Oncogene.

[2]  J. Rui,et al.  [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[3]  Jing He,et al.  [Effects of the novel gene, LAPTM4B, highly expression in hepatocellular carcinoma on cell proliferation and tumorigenesis of NIH3T3 cells]. , 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[4]  A. Shevchenko,et al.  Resistance of cell membranes to different detergents , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Rui,et al.  Right trisectionectomy for primary liver cancer. , 2003, World journal of gastroenterology.

[6]  J. Rui.  66: Right Trisectionectomy for Primary Liver Cancer , 2003 .

[7]  A. Zhu.  Hepatocellular Carcinoma: Are We Making Progress? , 2003, Cancer investigation.

[8]  Seong-Jin Kim,et al.  Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. , 2002, Cancer research.

[9]  V. Ling,et al.  Lysosome-associated protein transmembrane 4 alpha (LAPTM4 alpha) requires two tandemly arranged tyrosine-based signals for sorting to lysosomes. , 2002, The Biochemical journal.

[10]  L. Qin,et al.  The prognostic molecular markers in hepatocellular carcinoma. , 2002, World journal of gastroenterology.

[11]  L. Liu,et al.  Expression, Purification, Characterization of Amphioxus Insulin-like Peptide and Preparation of Polyclonal Antibody to It. , 2001, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.

[12]  N. Sherman,et al.  Differential extraction and enrichment of human sperm surface proteins in a proteome: Identification of immunocontraceptive candidates , 2001, Electrophoresis.

[13]  R. Gorczynski,et al.  Preparation and functional properties of polyclonal and monoclonal antibodies to murine MD-1. , 2001, Immunology letters.

[14]  W. Woloszczuk,et al.  Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. , 2001, European journal of medical research.

[15]  Y. Liu,et al.  Identification of metastasis associated gene G3BP by differential display in human cancer cell sublines with different metastatic potentials G3BP as highly expressed in non-metastatic. , 2001, Chinese Medical Journal.

[16]  C. Jin,et al.  Biological function of a novel gene overexpressed in human hepatocellular carcinoma. , 2000, Chinese Medical Journal.

[17]  A. Ryo,et al.  Identification and characterization of genes associated with human hepatocellular carcinogenesis. , 1999, Cancer research.

[18]  C. Cass,et al.  Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes. , 1999, Cancer research.

[19]  H. Zhong,et al.  [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential]. , 1999, Zhonghua yi xue za zhi.

[20]  V. Ling,et al.  A Mammalian Lysosomal Membrane Protein Confers Multidrug Resistance upon Expression in Saccharomyces cerevisiae * , 1999, The Journal of Biological Chemistry.

[21]  M. N. Jones,et al.  Surfactants in membrane solubilisation. , 1999, International journal of pharmaceutics.

[22]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[23]  J. Rui,et al.  Detection of hepatoma cells in peripheral blood of HCC patients by nested RT-PCR. , 1998, World journal of gastroenterology.

[24]  Qifu Liu,et al.  Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas. , 1998, World journal of gastroenterology.

[25]  D. Sansonno,et al.  In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus‐related antigens in hepatocellular carcinoma , 1997 .

[26]  J. Fujimoto,et al.  Expression of hepatocyte growth factor and its receptor c‐met proto‐oncogene in hepatocellular carcinoma , 1997, Hepatology.

[27]  C. Cass,et al.  Identification of a Novel Membrane Transporter Associated with Intracellular Membranes by Phenotypic Complementation in the Yeast Saccharomyces cerevisiae(*) , 1996, The Journal of Biological Chemistry.

[28]  M. Golding,et al.  Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. , 1995, Cancer research.